The African Union will pay three times more for Russia’s Sputnik V jab than it is paying for the Oxford/AstraZeneca and Novavax vaccines, according to people familiar with the procurement process.
The $9.75 price per dose for 300m shots of the Russian vaccine, developed by the state-run Gamaleya Institute, undermines Moscow’s argument that it is offering affordable jabs to countries priced out of deals with western pharmaceutical groups.
The deals struck by the AU, which is emerging as one of the world’s biggest vaccine buyers, provide a rare insight into how jab prices compare, a subject manufacturers have sought to keep out of the spotlight.
您已阅读21%（649字），剩余79%（2403字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。